HBME-1 IMMUNOSTAINING IN REACTIVE MESOTHELIAL CELLS VS. METASTATIC ADENOCARCINOMA IN SEROUS FLUIDS

被引：0
|
作者：
Moghaddam, N. Afshar
Zahedi, M. Dehghani
Rahmani, A.
Tahririan, R.
Heidarian, H.
机构：
[1] Isfahan Univ Med Sci, Fac Med, Dept Pathol, Esfahan, Iran
[2] Isfahan Univ Med Sci, Fac Med, Dept Gastroenterol, Esfahan, Iran
[3] Afshar Pathobiol Lab, Esfahan, Iran
[4] Bandar Abbas Univ Med Sci, Fac Med, Dept Pathol, Bandar Abbas, Iran
来源：
ACTA CYTOLOGICA | 2010年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [21] Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion
    Ueda, J
    Iwata, T
    Ono, M
    Takahashi, M
    DIAGNOSTIC CYTOPATHOLOGY, 2006, 34 (01) : 6 - 10
  • [22] Anti-MOC 31 evaluation of cytologic fluids: Adenocarcinoma versus reactive mesothelial cells.
    Morgan, RL
    McGaughy, VR
    De Young, BR
    Niemann, TH
    MODERN PATHOLOGY, 1998, 11 (01) : 41A - 41A
  • [23] The mRNA expression of specific markers for distinguishing between reactive mesothelial cells and adenocarcinoma in body cavity fluids
    Yamamoto, Y.
    Hata, K.
    Ohsaki, H.
    Yamanushi, T. T.
    Hirakawa, E.
    ACTA CYTOLOGICA, 2007, 51 (02) : 301 - 301
  • [24] Utility of MOC-31 monoclonal antibody in differentiating metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cytology
    Patil, Bharat
    Shivkumar, Vitaladevuni
    Gangane, Nitin
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 90 - 93
  • [25] PAX 8 as a Reliable Marker to Differentiate a Reactive Mesothelial Cells from Metastatic Gyn Carcinoma in Serous Effusion Cytology
    Sanguino, A. M.
    Liu, Y.
    Mohanty, A.
    Krishnamurti, U.
    Silverman, J.
    MODERN PATHOLOGY, 2014, 27 : 119A - 119A
  • [26] PAX 8 as a Reliable Marker to Differentiate a Reactive Mesothelial Cells from Metastatic Gyn Carcinoma in Serous Effusion Cytology
    Sanguino, A. M.
    Liu, Y.
    Mohanty, A.
    Krishnamurti, U.
    Silverman, J.
    LABORATORY INVESTIGATION, 2014, 94 : 119A - 119A
  • [27] Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma - Utility of combined E-cadherin and calretinin immunostaining
    Kitazume, H
    Kitamura, K
    Mukai, K
    Inayama, Y
    Kawano, N
    Nakamura, N
    Sano, J
    Mitsui, K
    Yoshida, S
    Nakatani, Y
    CANCER CYTOPATHOLOGY, 2000, 90 (01): : 55 - 60
  • [28] Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura
    González-Lois, C
    Ballestín, C
    Sotelo, MT
    López-Ríos, F
    García-Prats, MD
    Villena, V
    HISTOPATHOLOGY, 2001, 38 (06) : 528 - 534
  • [29] Diagnostic usefulness of MUC1 and MUC4 for distinguishing between metastatic adenocarcinoma cells and reactive mesothelial cells in effusion cell blocks
    Lee, J. S.
    Kim, G. -E.
    Lee, J. H.
    Choi, C.
    VIRCHOWS ARCHIV, 2012, 461 : S77 - S77
  • [30] Diagnostic Usefulness of MUC1 and MUC4 for Distinguishing between Metastatic Adenocarcinoma Cells and Reactive Mesothelial Cells in Effusion Cell Blocks
    Cho, Jin Seong
    Kim, Ga-Eon
    Lee, Ji Shin
    Lee, Jae Hyuk
    Nam, Jong Hee
    Choi, Chan
    ACTA CYTOLOGICA, 2013, 57 (04) : 377 - 383
12345